Cold denaturation of monoclonal antibodies

mAbs

Volumn 2, Issue 1, 2010, Pages 42-52

  Lazar, Kristi L ^a   Patapoff, Thomas W ^a   Sharma, Vikas K ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANIDINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1; MONOCLONAL ANTIBODY 2; POLYPROLINE; PROLINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; CIRCULAR DICHROISM; COLD; CONTROLLED STUDY; FLUORESCENCE; MOLECULAR MODEL; PH; PROTEIN ANALYSIS; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; SPECTROSCOPY; TEMPERATURE; THERMODYNAMICS;

ANTIBODIES, MONOCLONAL; CALORIMETRY, DIFFERENTIAL SCANNING; CIRCULAR DICHROISM; COLD TEMPERATURE; COMPUTER SIMULATION; DRUG STORAGE; HUMANS; IMMUNOGLOBULIN G; MODELS, CHEMICAL; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN STABILITY; SPECTROMETRY, FLUORESCENCE; THERMODYNAMICS;

EID: 77953674463     PISSN: 19420862     EISSN: None     Source Type: Journal    
DOI: 10.4161/mabs.2.1.10787     Document Type: Article

References (59)

1. Wang W, Singh S, Zeng DL, King K, Nema S. Antibody structure, instability and formulation. J Pharm Sci 2007; 96:1-26.
2. Carter PJ. Potent antibody therapeutics by design. Nat Rev Immunol 2006; 6:343-57.
3. Borrebaeck CA. Antibodies in diagnostics: From immunoassays to protein chips. Immunol Today 2000; 21:379-82.
4. Goldman RD. Antibodies: indispensable tools for biomedical research. Trends Biochem Sci 2000; 25:593-5.
5. Webb SD, Webb JN, Hughes TG, Sesin DF, Kincaid AC. Freezing bulk-scale biopharmaceuticals using common techniques and the magnitude of freeze-concentration. BioPharm 2002; 15:22-34.
6. Rathore N, Rajan RS. Current perspectives on stability of protein drug products during formulation, fill and finish operations. Biotechnol Prog 2008; 24:504-14.
7. Lashmar UT, Vanderburgh M, Little SJ. Bulk freezethawing of macromolecules: Effects of cryoconcentration on their formulation and stability. BioProcess Int 2007; 5:44-54.
8. Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: Separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol 2007; 12:505-23.
9. Liu L, Kueltzo L, Jones L, Carpenter J. Freezinginduced perturbation of tertiary structure of monoclonal antibody. AAPS J 2006; 8:2.
10. Privalov PL. Cold denaturation of proteins. Crit Rev Biochem Mol Biol 1990; 25:281-305.
11. Kueltzo LA, Wang W, Randolph TW, Carpenter JF. Effects of solution conditions, processing parameters and container materials on aggregation of a monoclonal antibody during freeze-thawing. J Pharm Sci 2008; 97:1801-12.
12. Becktel WJ, Schellman JA. Protein stability curves. Biopolymers 1987; 26:1859-77.
13. Kumar S, Tsai CJ, Nussinov R. Thermodynamic differences among homologous thermophilic and mesophilic proteins. Biochemistry 2001; 40:14152-65.
14. Kumar S, Tsai CJ, Nussinov R. Maximal stabilities of reversible two-state proteins. Biochemistry 2002; 41:5359-74.
15. Lopez CF, Darst RK, Rossky PJ. Mechanistic elements of protein cold denaturation. J Phys Chem B 2008; 112:5961-7.
16. Davidovic M, Mattea C, Qvist J, Halle B. Protein cold denaturation as seen from the solvent. J Am Chem Soc 2009; 131:1025-36.
17. Privalov PL, Griko YV, Venyaminov SY, Kutyshenko VP. Cold denaturation of myoglobin. J Mol Biol 1986; 190:487-98.
18. Griko YV, Venyaminov SY, Privalov PL. Heat and cold denaturation of Phosphoglycerate Kinase (Interaction of domains). FEBS Lett 1989; 244:276-8.
19. Griko YV, Privalov PL. Calorimetric study of the heat and cold denaturation of beta-lactoglobulin. Biochemistry 1992; 31:8810-5.
20. Zhang J, Peng X, Jonas A, Jonas J. NMR-study of the cold, heat and pressure unfolding of ribonuclease-A. Biochemistry 1995; 34:8631-41.
21. Ibarra-Molero B, Makhatadze GI, Sanchez-Ruiz JM. Cold denaturation of ubiquitin. Biochim Biophys Acta 1999; 1429:384-90.
22. Pastore A, Martin SR, Politou A, Kondapalli KC, Stemmler T, Temussi PA. Unbiased cold denaturation: Low- and high-temperature unfolding of yeast frataxin under physiological conditions. J Am Chem Soc 2007; 129:5374-5375.
23. Pace CN. Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods Enzymol 1986; 131:266-80.
24. Pace CN, Shaw KL. Linear extrapolation method of analyzing solvent denaturation curves. Proteins 2000; 4:1-7.
25. Bushell SR, Bottomley SP, Rossjohn J, Beddoe T. Tracking the unfolding pathway of a multirepeat protein via tryptophan scanning: Evidence of localized instability in the mitochondrial import receptor Tom70. J Biol Chem 2006; 281:24345-50.
26. Masino L, Martin SR, Bayley PM. Ligand binding and thermodynamic stability of a multidomain protein, calmodulin. Protein Sci 2000; 9:1519-29.
27. Ionescu RM, Smith VF, O'Neill JC, Matthews CR. Multistate equilibrium unfolding of Escherichia coli dihydrofolate reductase: Thermodynamic and spectroscopic description of the native, intermediate and unfolded ensembles. Biochemistry 2000; 39:9540-50.
28. Kleppe R, Uhlemann K, Knappskog PM, Haavik J. Urea-induced denaturation of human phenylalanine hydroxylase. J Biol Chem 1999; 274:33251-8.
29. Park YC, Bedouelle H. Dimeric tyrosyl-tRNA synthetase from Bacillus stearothermophilus unfolds through a monomeric intermediate: A quantitative analysis under equilibrium conditions. J Biol Chem 1998; 273:18052-9.
30. Morjana NA, Mckeone BJ, Gilbert HF. Guanidinehydrochloride stabilization of a partially unfolded intermediate during the reversible denaturation of protein disulfide-isomerase. Proc Natl Acad Sci USA 1993; 90:2107-2111.
31. Barrick D, Baldwin RL. 3-State analysis of sperm whale apomyoglobin folding. Biochemistry 1993; 32:3790-6.
32. Nozaki Y. The preparation of guanidine hydrochloride. Methods Enzymol 1972; 26:43-50.
33. Sumi A, Hamaguchi K. Denaturation by guanidinehydrochloride of the Fc(T) and Pfc' fragments of human-immunoglobulin G. J Biochem (Tokyo) 1982; 92:823-33.
34. Rowe ES. Dissociation and denaturation equilibria and kinetics of a homogeneous human immunoglobulin Fab fragment. Biochemistry 1976; 15:905-16.
35. Rowe ES, Tanford C. Equilibrium and kinetics of the denaturation of a homogeneous human immunoglobulin light chain. Biochemistry 1973; 12:4822-7.
36. Rothlisberger D, Honegger A, Pluckthun A. Domain interactions in the Fab fragment: A comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. J Mol Biol 2005; 347:773-89.
37. Myers JK, Pace CN, Scholtz JM. Denaturant m-values and heat-capacity changes: Relation to changes in accessible surface-areas of protein unfolding. Protein Sci 1995; 4:2138-48.
38. Englander SW, Epstein HT. Optical methods for measuring nucleoprotein and nucleic acid concentrations. Arch Biochem Biophys 1957; 68:144-9.
39. Tiffany ML, Krimm S. Effect of temperature on the circular dichroism spectra of polypeptides in the extended state. Biopolymers 1972; 11:2309-16.
40. Shi Z, Chen K, Liu Z, Kallenbach NR. Conformation of the backbone in unfolded proteins. Chem Rev 2006; 106:1877-97.
41. Rucker AL, Creamer TP. Polyproline II helical structure in protein unfolded states: Lysine peptides revisited. Protein Sci 2002; 11:980-5.
42. Whittington SJ, Chellgren BW, Hermann VM, Creamer TP. Urea promotes polyproline II helix formation: Implications for protein denatured states. Biochemistry 2005; 44:6269-75.
43. Tiffany ML, Krimm S. Extended conformations of polypeptides and proteins in urea and guanidine hydrochloride. Biopolymers 1973; 12:575-87.
44. Privalov PL, Khechinashvili NN. A thermodynamic approach to the problem of stabilization of globular protein structure: A calorimetric study. J Mol Biol 1974; 86:665-84.
45. Ejima D, Tsumoto K, Fukada H, Yumioka R, Nagase K, Arakawa T, et al. Effects of acid exposure on the conformation, stability and aggregation of monoclonal antibodies. Proteins-Structure Function and Bioinformatics 2007; 66:954-62.
46. Vermeer AWP, Norde W. The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. Biophys J 2000; 78:394-404.
47. Han JH, Batey S, Nickson AA, Teichmann SA, Clarke J. The folding and evolution of multidomain proteins. Nat Rev Mol Cell Biol 2007; 8:319-30.
48. Randles LG, Batey S, Steward A, Clarke J. Distinguishing specific and nonspecific interdomain interactions in multidomain proteins. Biophys J 2008; 94:622-8.
49. Tischenko VM, Abramov VM, Zav'yalov VP. Investigation of the cooperative structure of Fe fragments from myeloma immunoglobulin G. Biochemistry 1998; 37:5576-81.
50. Goto Y, Ichimura N, Hamaguchi K. Effects of ammonium sulfate on the unfolding and refolding of the variable and constant fragments of an immunoglobulin light chain. Biochemistry 1988; 27:1670-7.
51. Presta LG, Chen H, OConnor SJ, Chisholm V, Meng YG, Krummen L, et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 1997; 57:4593-9.
52. Carter P, Presta L, Gorman CM, Ridgway JBB, Henner D, Wong WLT, et al. Humanization of an anti-P185 her2 antibody for human cancer therapy. Proc Natl Acad Sci USA 1992; 89:4285-9.
53. Ewert S, Huber T, Honegger A, Pluckthun A. Biophysical properties of human antibody variable domains. J Mol Biol 2003; 325:531-53.
54. 1-Immunoglobulin. Biochemistry 1985; 24:6467-74.
55. Kessler H, Mronga S, Muller G, Moroder L, Huber R. Conformational analysis of a IgG1 hinge peptide derivative in solution determined by NMR spectroscopy and refined by restrained molecular dynamics simulations. Biopolymers 1991; 31:1189-204.
56. Adzhubei AA, Sternberg MJE. Conservation of polyproline II helices in homologous proteins: Implications for structure prediction by model building. Protein Sci 1994; 3:2395-410.
57. Okajima T, Kawata Y, Hamaguchi K. Chemical modification of tryptophan residues and stability changes in proteins. Biochemistry 1990; 29:9168-75.
58. Roxana MI, Josef V, Colleen P, Marc K. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. J Pharm Sci 2008; 97:1414-26.
59. Tang XL, Pikal MJ. The effect of stabilizers and denaturants on the cold denaturation temperatures of proteins and implications for freeze-drying. Pharm Res 2005; 22:1167-75.